Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study

<b>Background:</b> This study evaluated titers and amplitudes of anti-E2 antibodies (anti-E2-Abs) and neutralizing antibodies against hepatitis C virus (HCV; anti-HCV-nAbs) in HIV/HCV-coinfected individuals over five years after successful HCV treatment completion. <b>Methods:</...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Sepúlveda-Crespo, Camilla Volpi, Rafael Amigot-Sánchez, María Belén Yélamos, Cristina Díez, Julián Gómez, Víctor Hontañón, Juan Berenguer, Juan González-García, Rubén Martín-Escolano, Salvador Resino, Isidoro Martínez
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Pharmaceuticals
Subjects:
HIV
hepatitis C
anti-HCV therapy
broad-spectrum neutralizing antibodies
HIV/HCV coinfection
sustained virologic response
Online Access:https://www.mdpi.com/1424-8247/17/9/1152
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/17/9/1152

Similar Items